• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人CYP3A4和2C8对紫杉烷类化合物的区域选择性代谢:构效关系

Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship.

作者信息

Cresteil Thierry, Monsarrat Bernard, Dubois Joelle, Sonnier Michelle, Alvinerie Paul, Gueritte Françoise

机构信息

Centre National de la Recherche Scientifique Unité Mixte Recherche 8532, Villejuif, France.

出版信息

Drug Metab Dispos. 2002 Apr;30(4):438-45. doi: 10.1124/dmd.30.4.438.

DOI:10.1124/dmd.30.4.438
PMID:11901098
Abstract

Paclitaxel and docetaxel are metabolized by liver microsomal monooxygenases into inactive metabolites further eliminated from the body via the bile route. In spite of their close chemical structure, the two drugs are oxidized by two different enzymes; CYP2C8 catalyzes the 6-hydroxylation on the taxane ring of paclitaxel, whereas CYP3A4 oxidizes docetaxel on the tert-butyl group of the lateral chain in C13. Since paclitaxel and docetaxel differ only by two substitutions, the role of individual modifications was investigated; the regioselectivity of hydroxylation was assessed by high-pressure liquid chromatography/mass spectrometry, and enzymes implicated in individual reactions were identified using human liver microsomes and recombinant P450 expressed in Ad293 cells. The biotransformation of docetaxel, 10-deacetylpaclitaxel, and 10-deacetylbaccatin III was steadily increased (2- to 5-fold) by the addition of an acetyl group in position 10, suggesting that the presence of a hydrophobic group in position 10 stimulated hydroxylation by P450 proteins. The absence of the lateral chain at C13 in baccatin III severely impaired the metabolism supported by CYP3A4. The presence of a tert-butyl group in the lateral chain of docetaxel favored the hydroxylation on the tert-butyl by CYP3A4, whereas the presence of a phenyl group in the lateral chain facilitated the oxidation on the taxane ring by CYP2C8. Collectively, these data strongly suggested that the structure of the lateral chain and the nature of substituent in position 10 play an important role in determining the regioselective oxidation by P450 proteins and modulate the reaction rate by human liver microsomes.

摘要

紫杉醇和多西他赛经肝脏微粒体单加氧酶代谢为无活性代谢产物,进而通过胆汁途径从体内清除。尽管它们的化学结构相似,但这两种药物由两种不同的酶氧化;细胞色素P450 2C8(CYP2C8)催化紫杉醇紫杉烷环上的6-羟基化反应,而细胞色素P450 3A4(CYP3A4)氧化多西他赛侧链C13位的叔丁基。由于紫杉醇和多西他赛仅相差两个取代基,因此研究了单个修饰的作用;通过高压液相色谱/质谱法评估羟基化的区域选择性,并使用人肝微粒体和在Ad293细胞中表达的重组P450鉴定参与单个反应的酶。在10位添加乙酰基后,多西他赛、10-去乙酰紫杉醇和10-去乙酰浆果赤霉素III的生物转化稳步增加(2至5倍),这表明10位存在疏水基团可刺激P450蛋白介导的羟基化反应。浆果赤霉素III的C13位没有侧链严重损害了CYP3A4支持的代谢。多西他赛侧链中存在叔丁基有利于CYP3A4对叔丁基的羟基化,而侧链中存在苯基则促进了CYP2C8对紫杉烷环的氧化。总体而言,这些数据有力地表明,侧链结构和10位取代基的性质在决定P450蛋白的区域选择性氧化以及调节人肝微粒体的反应速率方面起着重要作用。

相似文献

1
Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship.人CYP3A4和2C8对紫杉烷类化合物的区域选择性代谢:构效关系
Drug Metab Dispos. 2002 Apr;30(4):438-45. doi: 10.1124/dmd.30.4.438.
2
Biotransformation of taxoids by human cytochromes P450: structure-activity relationship.人细胞色素P450对紫杉烷类的生物转化:构效关系
Bull Cancer. 1997 Feb;84(2):125-33.
3
Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.对硫磷在人肝脏中的生物转化:CYP3A4的参与及其在微粒体对硫磷氧化过程中的失活
J Pharmacol Exp Ther. 1997 Feb;280(2):966-73.
4
Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.在人肝微粒体中,细胞色素P-450 2C8和P-450 3A4催化曲格列酮氧化为醌型代谢物。
Drug Metab Dispos. 1999 Nov;27(11):1260-6.
5
Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.花生四烯酸、前列腺素、视黄醇、视黄酸和胆钙化醇对人细胞色素P450酶催化的外源物氧化的影响。
Xenobiotica. 1999 Mar;29(3):231-41. doi: 10.1080/004982599238632.
6
Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.多西他赛(泰索帝)在体外的肝脏生物转化:CYP3A亚家族在人体中的作用。
Cancer Res. 1996 Mar 15;56(6):1296-302.
7
16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.人细胞色素P4503A4/5对雌酮的16α-羟基化作用。
Carcinogenesis. 1998 May;19(5):867-72. doi: 10.1093/carcin/19.5.867.
8
Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.多西他赛在人细胞色素P450中的代谢:与紫杉醇及其他抗肿瘤药物的相互作用
Cancer Res. 1996 Jan 1;56(1):58-65.
9
Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.紫杉烷在C3'位的取代基影响其区域选择性代谢:头状紫杉碱和紫杉醇的体外代谢差异。
Drug Metab Dispos. 2008 Feb;36(2):418-26. doi: 10.1124/dmd.107.018242. Epub 2007 Nov 26.
10
Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.人肝微粒体中CYP2C9和CYP2C19将(+)-和(-)-柠檬烯分别代谢为香芹醇和紫苏醇。
Drug Metab Dispos. 2002 May;30(5):602-7. doi: 10.1124/dmd.30.5.602.

引用本文的文献

1
Paclitaxel Drug-Drug Interactions in the Military Health System.军事卫生系统中紫杉醇的药物相互作用
Fed Pract. 2024 Aug;41(Suppl 3):S70-S82. doi: 10.12788/fp.0499. Epub 2024 Aug 15.
2
Study on Cytochrome P450 Metabolic Profile of Paclitaxel on Rats using QTOF-MS.采用 QTOF-MS 技术研究紫杉醇在大鼠体内的细胞色素 P450 代谢谱。
Curr Drug Metab. 2024;25(5):330-339. doi: 10.2174/0113892002308509240711100502.
3
Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer.
用于揭示多个单核苷酸多态性相互作用以预测非小细胞肺癌患者紫杉醇清除率的新型渐进式深度学习算法。
Cancer Innov. 2024 May 12;3(4):e110. doi: 10.1002/cai2.110. eCollection 2024 Aug.
4
Down-Regulation of CYP3A4 by the K1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models.K1.1 抑制下调 CYP3A4 负责克服癌症球体模型中对多柔比星的耐药性。
Int J Mol Sci. 2023 Oct 27;24(21):15672. doi: 10.3390/ijms242115672.
5
Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients.肿瘤细胞色素 P450 拷贝数改变与肺腺癌患者化疗耐药的相关性研究。
Int J Mol Sci. 2023 Aug 29;24(17):13380. doi: 10.3390/ijms241713380.
6
Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.细胞色素 P450 氧化还原酶(POR)与欧洲裔 ECOG-ACRIN E5103 患者中严重紫杉醇诱导的周围神经病相关。
Clin Cancer Res. 2023 Jul 5;29(13):2494-2500. doi: 10.1158/1078-0432.CCR-22-2431.
7
Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.乳腺癌治疗的药物遗传学:撒哈拉以南非洲视角
Pharmgenomics Pers Med. 2022 Jun 21;15:613-652. doi: 10.2147/PGPM.S308531. eCollection 2022.
8
Drug-interaction between paclitaxel and goshajinkigan extract and its constituents.紫杉醇与獐牙菜苦苷提取物及其成分的药物相互作用。
J Nat Med. 2022 Jan;76(1):59-67. doi: 10.1007/s11418-021-01552-8. Epub 2021 Jul 25.
9
Mechanisms of Taxane Resistance.紫杉烷耐药机制。
Cancers (Basel). 2020 Nov 10;12(11):3323. doi: 10.3390/cancers12113323.
10
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes.细胞色素 P450 3A4、3A5 和 2C8 在乳腺癌、前列腺癌、肺癌、子宫内膜癌和卵巢癌中的表达:与紫杉烷类耐药的相关性。
Cancer Chemother Pharmacol. 2019 Sep;84(3):487-499. doi: 10.1007/s00280-019-03905-3. Epub 2019 Jul 15.